Literature DB >> 16200159

Plague: from natural disease to bioterrorism.

Stefan Riedel1.   

Abstract

Yersinia pestis is the causative agent of plague, an enzootic vectorborne disease usually infecting rodents (rats) and fleas. Humans can become infected after being bitten by fleas that have fed on infected rodents. In humans, the disease usually occurs in the form of bubonic plague. In rare cases, the infection spreads to the lungs via the bloodstream and causes secondary pneumonic plague. Person-to-person transmission has been described for pneumonic plague but is rare in primary bubonic plague. Bubonic plague can usually be treated successfully with antibiotics; however, pneumonic plague develops rapidly and carries a high fatality rate despite immediate treatment with antibiotics. Plague is also recognized as a potential agent of bioterrorism. It has been used, or considered for use, as a biologic weapon on several occasions. It is important for the medical community to be familiar with the epidemiology, diagnosis, and symptoms of plague so it can deliver an appropriate and calm response should the unthinkable happen.

Entities:  

Year:  2005        PMID: 16200159      PMCID: PMC1200711          DOI: 10.1080/08998280.2005.11928049

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  31 in total

Review 1.  Molecular and cell biology aspects of plague.

Authors:  G R Cornelis
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

Review 2.  Diagnosis of plaque: an analysis of the Yersin-Kitasato controversy.

Authors:  D J Bibel; T H Chen
Journal:  Bacteriol Rev       Date:  1976-09

3.  Determination of genome size, macrorestriction pattern polymorphism, and nonpigmentation-specific deletion in Yersinia pestis by pulsed-field gel electrophoresis.

Authors:  T S Lucier; R R Brubaker
Journal:  J Bacteriol       Date:  1992-04       Impact factor: 3.490

4.  Primary pneumonic plague in Mukden, 1946, and report of 39 cases with three recoveries.

Authors:  T H TIEH; E LANDAUER
Journal:  J Infect Dis       Date:  1948 Jan-Feb       Impact factor: 5.226

5.  Multidrug resistance in Yersinia pestis mediated by a transferable plasmid.

Authors:  M Galimand; A Guiyoule; G Gerbaud; B Rasoamanana; S Chanteau; E Carniel; P Courvalin
Journal:  N Engl J Med       Date:  1997-09-04       Impact factor: 91.245

6.  From the Centers for Disease Control and Prevention. Fatal human plague--Arizona and Colorado, 1996.

Authors: 
Journal:  JAMA       Date:  1997-08-06       Impact factor: 56.272

7.  The black death past and present. 2. Some historical problems.

Authors:  P Slack
Journal:  Trans R Soc Trop Med Hyg       Date:  1989 Jul-Aug       Impact factor: 2.184

8.  De Mussis and the great plague of 1348. A forgotten episode of bacteriological warfare.

Authors:  V J Derbes
Journal:  JAMA       Date:  1966-04-04       Impact factor: 56.272

9.  Antibiotic treatment of experimental pneumonic plague in mice.

Authors:  W R Byrne; S L Welkos; M L Pitt; K J Davis; R P Brueckner; J W Ezzell; G O Nelson; J R Vaccaro; L C Battersby; A M Friedlander
Journal:  Antimicrob Agents Chemother       Date:  1998-03       Impact factor: 5.191

10.  Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States.

Authors:  J A Jernigan; D S Stephens; D A Ashford; C Omenaca; M S Topiel; M Galbraith; M Tapper; T L Fisk; S Zaki; T Popovic; R F Meyer; C P Quinn; S A Harper; S K Fridkin; J J Sejvar; C W Shepard; M McConnell; J Guarner; W J Shieh; J M Malecki; J L Gerberding; J M Hughes; B A Perkins
Journal:  Emerg Infect Dis       Date:  2001 Nov-Dec       Impact factor: 6.883

View more
  28 in total

1.  Acquisition of maternal antibodies both from the placenta and by lactation protects mouse offspring from Yersinia pestis challenge.

Authors:  Zhizhen Qi; Haihong Zhao; Qingwen Zhang; Yujing Bi; Lingling Ren; Xuecan Zhang; Hanqing Yang; Xiaoyan Yang; Qiong Wang; Cunxiang Li; Jiyuan Zhou; Youquan Xin; Yonghai Yang; Huiying Yang; Zongmin Du; Yafang Tan; Yanping Han; Yajun Song; Lei Zhou; Pingping Zhang; Yujun Cui; Yanfeng Yan; Dongsheng Zhou; Ruifu Yang; Xiaoyi Wang
Journal:  Clin Vaccine Immunol       Date:  2012-08-29

2.  Development of a rapid viability polymerase chain reaction method for detection of Yersinia pestis.

Authors:  Staci R Kane; Sanjiv R Shah; Teneile M Alfaro
Journal:  J Microbiol Methods       Date:  2019-05-13       Impact factor: 2.363

3.  Yersinia pestis antibiotic resistance: a systematic review.

Authors:  Chen Lei; Suresh Kumar
Journal:  Osong Public Health Res Perspect       Date:  2022-02-18

4.  Long-term observation of subunit vaccine F1-rV270 against Yersinia pestis in mice.

Authors:  Zuyun Wang; Lei Zhou; Zhizhen Qi; Qingwen Zhang; Ruixia Dai; Yonghai Yang; Baizhong Cui; Hu Wang; Ruifu Yang; Xiaoyi Wang
Journal:  Clin Vaccine Immunol       Date:  2009-11-25

5.  Evaluation of YadC protein delivered by live attenuated Salmonella as a vaccine against plague.

Authors:  Wei Sun; Joseph Olinzock; Shifeng Wang; Shilpa Sanapala; Roy Curtiss
Journal:  Pathog Dis       Date:  2013-09-10       Impact factor: 3.166

6.  Braun lipoprotein (Lpp) contributes to virulence of yersiniae: potential role of Lpp in inducing bubonic and pneumonic plague.

Authors:  Jian Sha; Stacy L Agar; Wallace B Baze; Juan P Olano; Amin A Fadl; Tatiana E Erova; Shaofei Wang; Sheri M Foltz; Giovanni Suarez; Vladimir L Motin; Sadhana Chauhan; Gary R Klimpel; Johnny W Peterson; Ashok K Chopra
Journal:  Infect Immun       Date:  2008-01-28       Impact factor: 3.441

7.  Yersinia pestis biovar Microtus strain 201, an avirulent strain to humans, provides protection against bubonic plague in rhesus macaques.

Authors:  Qingwen Zhang; Qiong Wang; Guang Tian; Zhizhen Qi; Xuecan Zhang; Xiaohong Wu; Yefeng Qiu; Yujing Bi; Xiaoyan Yang; Youquan Xin; Jian He; Jiyuan Zhou; Lin Zeng; Ruifu Yang; Xiaoyi Wang
Journal:  Hum Vaccin Immunother       Date:  2013-11-13       Impact factor: 3.452

8.  Characterization of systemic and pneumonic murine models of plague infection using a conditionally virulent strain.

Authors:  Gabriela Mellado-Sanchez; Karina Ramirez; Cinthia B Drachenberg; Jovita Diaz-McNair; Ana L Rodriguez; James E Galen; James P Nataro; Marcela F Pasetti
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2012-11-26       Impact factor: 2.268

9.  Histopathological observation of immunized rhesus macaques with plague vaccines after subcutaneous infection of Yersinia pestis.

Authors:  Guang Tian; Yefeng Qiu; Zhizhen Qi; Xiaohong Wu; Qingwen Zhang; Yujing Bi; Yonghai Yang; Yuchuan Li; Xiaoyan Yang; Youquan Xin; Cunxiang Li; Baizhong Cui; Zuyun Wang; Hu Wang; Ruifu Yang; Xiaoyi Wang
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

10.  Modeling the Cost-Effectiveness of Interventions to Prevent Plague in Madagascar.

Authors:  Giovanni S P Malloy; Margaret L Brandeau; Jeremy D Goldhaber-Fiebert
Journal:  Trop Med Infect Dis       Date:  2021-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.